Mike has over 20 years of successful prescription pharmaceutical sales and marketing experience with specific responsibilities and expertise in sales management, product management, sales operations, merger acquisitions, and professional development. Mike’s experience includes “start-up” expertise while also a holding a number of increasing roles and responsibilities with traditional pharmaceutical companies most notably Sanofi-Aventis, Novartis, and UCB Pharma. Mike was responsible for the commercial development and successful launch of Ther-Rx Corporation a Women’s Health Specialty Pharmaceutical “start-up” where he was key contributor responsible for building the commercial team charged with the successful launch of over eight new products including a new orphan drug for pre-term pregnancy. Mike is a graduate of Neumann University and he earned his Master’s in Business Administration from Frostburg State University.
In his role as Chief Executive Officer, Deas is responsible for providing the day-to-day leadership decisions and for implementing Avions’ short and long term strategic goals. Deas previously held the position of Chief Operating Office for Acella Pharmaceuticals. Prior to Acella Pharmaceuticals, Mr. Deas was Vice President, Sales and Marketing for Alliant Pharmaceuticals, and was an integral component in the company’s overall success. Prior to Alliant, Deas served as Regional Sales Manager for Genentech Pharmaceuticals. The significant contributions Deas has made throughout his career within the pharmaceutical industry provides the necessary framework for future growth and sustainability.